Impact of Tight Glycaemic Control in Acute Myocardial Infarction

PHASE4TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Myocardial InfarctHyperglycemia
Interventions
DRUG

Insulin (tight blood glucose control)

Trial Locations (1)

3050

The Royal Melbourne Hospital, Melbourne

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

National Health and Medical Research Council, Australia

OTHER

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Melbourne Health

OTHER